Condition: Acute Heart Failure (AHF) · Sponsor: Aarhus University Hospital
This is a multicenter, randomized, double-blind, placebo-controlled trial to investigate the clinical efficacy of treatment with exogenous dietary ketone supplement containing 1,3-butanediol in patients hospitalized with acute heart failure (AHF), potentially leading to better clinical outcomes.
This description comes directly from the study's public registry record.
Kristoffer Berg-Hansen, MD, PhD · +4560540700 · krisbe@rm.dk
Henrik Wiggers, MD, PHD, DMSc · henrikwiggers@dadlnet.dk
Always discuss trial participation with your own doctor first.
| Department of Cardiology, Aalborg University Hospital | Aalborg, Denmark | Not Yet Recruiting |
| Department of Cardiology, Aarhus University Hospital | Aarhus N, Denmark | Recruiting |
| Department of Cardiology, Herlev-Gentofte Hospital | Copenhagen, Denmark | Recruiting |
| Department of Cardiology, Rigshospitalet | Copenhagen, Denmark | Not Yet Recruiting |
| Department of Cardiology, Gødstrup Hospital, Herning, Denmark | Herning, Denmark | Recruiting |
| Department of Cardiology, Copenhagen University Hospital - Amager and Hvidovre Hospital | Hvidovre, Denmark | Recruiting |
| Department of Cardiology, Odense University Hospital | Odense, Denmark | Not Yet Recruiting |
| Department of Cardiology, Viborg Hospital | Viborg, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06653725